{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:28:18Z","timestamp":1788262098385,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773080"],"award-info":[{"award-number":["81773080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07163-1","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:43:24Z","timestamp":1761047004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hidden risk factors for recurrence of jejunoileal Gastrointestinal stromal tumors with low NIH classification: implications for surveillance and adjuvant therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiangfei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-6508","authenticated-orcid":false,"given":"Kuntang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"1","key":"7163_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-021-00254-5","volume":"7","author":"JY Blay","year":"2021","unstructured":"Blay JY, Kang YK, Nishida T, et al. Gastrointestinal stromal tumours. Nat Rev Dis Primers. 2021;7(1):22. https:\/\/doi.org\/10.1038\/s41572-021-00254-5.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"7163_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.annonc.2021.09.005","volume":"33","author":"PG Casali","year":"2022","unstructured":"Casali PG, Blay JY, Abecassis N, et al. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(1):20\u201333. https:\/\/doi.org\/10.1016\/j.annonc.2021.09.005.","journal-title":"Ann Oncol"},{"issue":"12","key":"7163_CR3","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.29271\/jcpsp.2021.12.1487","volume":"31","author":"H Uzunoglu","year":"2021","unstructured":"Uzunoglu H, Tosun Y, Akinci O, et al. Gastrointestinal stromal tumours of the small Intestine. J Coll Physicians Surg Pak. 2021;31(12):1487\u201393. https:\/\/doi.org\/10.29271\/jcpsp.2021.12.1487.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"7163_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12029-009-9102-y","volume":"41","author":"HJ Sanchez","year":"2010","unstructured":"Sanchez HJ, Rufian PS, Ciria BR, et al. Gastrointestinal stromal tumors (GIST): a prospective evaluation of risk factors and prognostic scores. J Gastrointest Cancer. 2010;41(1):27\u201337. https:\/\/doi.org\/10.1007\/s12029-009-9102-y.","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"7163_CR5","first-page":"219","volume":"86","author":"G Belfiori","year":"2015","unstructured":"Belfiori G, Sartelli M, Cardinali L, et al. Risk stratification systems for surgically treated localized primary Gastrointestinal stromal tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen. Ann Ital Chir. 2015;86(3):219\u201327.","journal-title":"Ann Ital Chir"},{"issue":"8","key":"7163_CR6","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1245\/s10434-008-9969-z","volume":"15","author":"BK Goh","year":"2008","unstructured":"Goh BK, Chow PK, Yap WM, et al. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified armed forces Institute of pathology risk criteria. Ann Surg Oncol. 2008;15(8):2153\u201363. https:\/\/doi.org\/10.1245\/s10434-008-9969-z.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"7163_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.25122\/jml-2021-0110","volume":"15","author":"S Kersting","year":"2022","unstructured":"Kersting S, Janot-Matuschek MS, Schnitzler C, et al. GIST: correlation of risk classifications and outcome. J Med Life. 2022;15(8):932\u201343. https:\/\/doi.org\/10.25122\/jml-2021-0110.","journal-title":"J Med Life"},{"issue":"10\u201311","key":"7163_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1080\/00365521.2018.1515319","volume":"53","author":"B Zhao","year":"2018","unstructured":"Zhao B, Zhang J, Mei D, et al. The assessment of different risk classification systems for Gastrointestinal stromal tumors (GISTs): the analytic results from the SEER database. Scand J Gastroenterol. 2018;53(10\u201311):1319\u201327. https:\/\/doi.org\/10.1080\/00365521.2018.1515319.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"7163_CR9","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s12328-021-01464-w","volume":"14","author":"M Inoue","year":"2021","unstructured":"Inoue M, Shishida M, Watanabe A, et al. A liver metastasis 7 years after resection of a low-risk duodenal Gastrointestinal stromal tumor. Clin J Gastroenterol. 2021;14(5):1464\u20139. https:\/\/doi.org\/10.1007\/s12328-021-01464-w.","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"7163_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12876-025-03945-5","volume":"25","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li M, Bai X, et al. Unraveling the site-specific features in small intestinal stromal tumors: a retrospective study. BMC Gastroenterol. 2025;25(1):337. https:\/\/doi.org\/10.1186\/s12876-025-03945-5.","journal-title":"BMC Gastroenterol"},{"key":"7163_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17121934","author":"S Mantalovas","year":"2025","unstructured":"Mantalovas S, Karakousis VA, Sevva C, et al. Multifocal Gastrointestinal stromal tumors (GISTs) of the small intestine in patients with neurofibromatosis type 1 (NF-1): Meta-Analysis and systematic review of the Literature. Cancers (Basel). 2025;1210.3390\/cancers17121934.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"7163_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.6004\/jnccn.2022.0058","volume":"20","author":"M von Mehren","year":"2022","unstructured":"von Mehren M, Kane JM, Riedel RF, et al. NCCN Guidelines(R) insights: Gastrointestinal stromal Tumors, version 2.2022. J Natl Compr Canc Netw. 2022;20(11):1204\u201314. https:\/\/doi.org\/10.6004\/jnccn.2022.0058.","journal-title":"J Natl Compr Canc Netw"},{"key":"7163_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejca.2016.03.082","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Seymour L, Litiere S, et al. RECIST 1.1 - Standardisation and disease-specific adaptations: perspectives from the RECIST working Group. Eur J Cancer. 2016;62:138\u201345. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.082.","journal-title":"Eur J Cancer"},{"issue":"2","key":"7163_CR14","first-page":"131","volume":"123","author":"H Cao","year":"2010","unstructured":"Cao H, Zhang Y, Wang M, et al. Prognostic analysis of patients with Gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease. Chin Med J (Engl). 2010;123(2):131\u20136.","journal-title":"Chin Med J (Engl)"},{"issue":"19","key":"7163_CR15","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-23-1184","volume":"29","author":"JK Dermawan","year":"2023","unstructured":"Dermawan JK, Kelly C, Gao Z, et al. Novel genomic risk stratification model for primary Gastrointestinal stromal tumors (GIST) in the adjuvant therapy Era. Clin Cancer Res. 2023;29(19):3974\u201385. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1184.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7163_CR16","doi-asserted-by":"publisher","first-page":"e33806","DOI":"10.7759\/cureus.33806","volume":"15","author":"DA Neama","year":"2023","unstructured":"Neama DA, Al AS, Alderazi AE, et al. Gastrointestinal stromal tumor recurrence presenting as a small bowel obstruction: A case Report. Cureus. 2023;15(1):e33806. https:\/\/doi.org\/10.7759\/cureus.33806.","journal-title":"Cureus"},{"issue":"12","key":"7163_CR17","first-page":"1521","volume":"44","author":"Y Terada","year":"2017","unstructured":"Terada Y, Sonoda H, Miyake T, et al. [A case of small intestinal GIST with Long-Term survival after tumor resection for repeated peritoneal Recurrence]. Gan Kagaku Ryoho. 2017;44(12):1521\u20132.","journal-title":"Gan Kagaku Ryoho"},{"issue":"11","key":"7163_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3760\/cma.j.cn441530-20240904-00303","volume":"27","author":"LX Yang","year":"2024","unstructured":"Yang LX, Yang WL, Wu X, et al. [Prognosis and its influencing factors in patients with non-gastric Gastrointestinal stromal tumors at low risk of recurrence: a retrospective multicenter study in China]. Zhonghua Wei Chang Wai Ke Za Zhi. 2024;27(11):1123\u201332. https:\/\/doi.org\/10.3760\/cma.j.cn441530-20240904-00303.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"3","key":"7163_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/cncr.23199","volume":"112","author":"RP Dematteo","year":"2008","unstructured":"Dematteo RP, Gold JS, Saran L, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary Gastrointestinal stromal tumor (GIST). Cancer. 2008;112(3):608\u201315. https:\/\/doi.org\/10.1002\/cncr.23199.","journal-title":"Cancer"},{"issue":"11","key":"7163_CR20","doi-asserted-by":"publisher","first-page":"e48372","DOI":"10.1371\/journal.pone.0048372","volume":"7","author":"G Schiavon","year":"2012","unstructured":"Schiavon G, Ruggiero A, Schoffski P, et al. Tumor volume as an alternative response measurement for Imatinib treated GIST patients. PLoS ONE. 2012;7(11):e48372. https:\/\/doi.org\/10.1371\/journal.pone.0048372.","journal-title":"PLoS ONE"},{"key":"7163_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12885-015-1054-y","volume":"15","author":"K Kramer","year":"2015","unstructured":"Kramer K, Knippschild U, Mayer B, et al. Impact of age and gender on tumor related prognosis in Gastrointestinal stromal tumors (GIST). BMC Cancer. 2015;15:57. https:\/\/doi.org\/10.1186\/s12885-015-1054-y.","journal-title":"BMC Cancer"},{"issue":"7","key":"7163_CR22","first-page":"1914","volume":"7","author":"D Sozutek","year":"2014","unstructured":"Sozutek D, Yanik S, Akkoca AN, et al. Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced\/metastatic disease. Int J Clin Exp Med. 2014;7(7):1914\u201322.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"7163_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1590\/s0102-86502012000500007","volume":"27","author":"NR Artigiani","year":"2012","unstructured":"Artigiani NR, Logullo AF, Stavale JN, et al. Ki-67 expression score correlates to survival rate in Gastrointestinal stromal tumors (GIST). Acta Cir Bras. 2012;27(5):315\u201321. https:\/\/doi.org\/10.1590\/s0102-86502012000500007.","journal-title":"Acta Cir Bras"},{"issue":"2","key":"7163_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/s0004-28032009000200008","volume":"46","author":"LR Neves","year":"2009","unstructured":"Neves LR, Oshima CT, Artigiani-Neto R, et al. Ki67 and p53 in Gastrointestinal stromal tumors\u2013GIST. Arq Gastroenterol. 2009;46(2):116\u201320. https:\/\/doi.org\/10.1590\/s0004-28032009000200008.","journal-title":"Arq Gastroenterol"},{"issue":"11","key":"7163_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.prp.2011.09.008","volume":"207","author":"MR Cerski","year":"2011","unstructured":"Cerski MR, Pereira F, Matte US, et al. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST. Pathol Res Pract. 2011;207(11):701\u20136. https:\/\/doi.org\/10.1016\/j.prp.2011.09.008.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"7163_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ijc.35379","volume":"157","author":"H Wu","year":"2025","unstructured":"Wu H, Yang X, Guo W. Survival outcomes in small intestine tumors: the role of duodenum, jejunum, and ileum. Int J Cancer. 2025;157(3):445\u201354. https:\/\/doi.org\/10.1002\/ijc.35379.","journal-title":"Int J Cancer"},{"issue":"11","key":"7163_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.17235\/reed.2024.10108\/2023","volume":"116","author":"OM Gomez","year":"2024","unstructured":"Gomez OM, Valdivielso CE, Cabezal IC, et al. Jejunal Gastrointestinal stromal tumor: a diagnostic challenge. Rev Esp Enferm Dig. 2024;116(11):636\u20137. https:\/\/doi.org\/10.17235\/reed.2024.10108\/2023.","journal-title":"Rev Esp Enferm Dig"},{"issue":"5","key":"7163_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.24875\/CIRU.22000464","volume":"92","author":"JJ Vargas-Montes","year":"2024","unstructured":"Vargas-Montes JJ, Yado-Lopez ME, Huerta-Martinez PL, et al. Proximal jejunal GIST associated with massive Gastrointestinal bleeding. Case report. Cir Cir. 2024;92(5):679\u201382. https:\/\/doi.org\/10.24875\/CIRU.22000464.","journal-title":"Cir Cir"},{"issue":"4","key":"7163_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00000478-200604000-00008","volume":"30","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Makhlouf H, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before Imatinib with long-term follow-up. Am J Surg Pathol. 2006;30(4):477\u201389. https:\/\/doi.org\/10.1097\/00000478-200604000-00008.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"7163_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12029-021-00650-w","volume":"54","author":"SS Nagaraj","year":"2023","unstructured":"Nagaraj SS, Deivasigamani S, Aruni A, et al. Diagnostic and therapeutic challenges in the management of acute massive overt bleeding of jejunal Gastrointestinal stromal tumours: case Series. J Gastrointest Cancer. 2023;54(1):316\u201322. https:\/\/doi.org\/10.1007\/s12029-021-00650-w.","journal-title":"J Gastrointest Cancer"},{"issue":"35","key":"7163_CR31","doi-asserted-by":"publisher","first-page":"e30098","DOI":"10.1097\/MD.0000000000030098","volume":"101","author":"B Jablonska","year":"2022","unstructured":"Jablonska B, Szmigiel P, Wosiewicz P, et al. A jejunal Gastrointestinal stromal tumor with massive Gastrointestinal hemorrhage treated by emergency surgery: A case report. Med (Baltim). 2022;101(35):e30098. https:\/\/doi.org\/10.1097\/MD.0000000000030098.","journal-title":"Med (Baltim)"},{"issue":"10","key":"7163_CR32","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3748\/wjg.v23.i10.1920","volume":"23","author":"C Ma","year":"2017","unstructured":"Ma C, Hao SL, Liu XC, et al. Supraclavicular lymph node metastases from malignant Gastrointestinal stromal tumor of the jejunum: A case report with review of the literature. World J Gastroenterol. 2017;23(10):1920\u20134. https:\/\/doi.org\/10.3748\/wjg.v23.i10.1920.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"7163_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.annonc.2025.05.535","volume":"36","author":"JY Blay","year":"2025","unstructured":"Blay JY, Devin Q, Toulmonde M, et al. Twenty-year survival of advanced Gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial. Ann Oncol. 2025;36(9):1035\u201346. https:\/\/doi.org\/10.1016\/j.annonc.2025.05.535.","journal-title":"Ann Oncol"},{"issue":"1","key":"7163_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12672-025-02454-x","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen L, Lu Y, Qian J, et al. Clinical characteristics and prognosis of non-metastatic multiple Gastrointestinal stromal tumors: a population-based study. Discov Oncol. 2025;16(1):643. https:\/\/doi.org\/10.1007\/s12672-025-02454-x.","journal-title":"Discov Oncol"},{"issue":"6","key":"7163_CR35","doi-asserted-by":"publisher","first-page":"100649","DOI":"10.1016\/j.esmoop.2022.100649","volume":"7","author":"NS IJzerman","year":"2022","unstructured":"IJzerman NS, van Werkhoven E, Mohammadi M, et al. Sex differences in patients with Gastrointestinal stromal tumours: do they exist and does it affect survival?. ESMO Open. 2022;7(6):100649. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100649.","journal-title":"ESMO Open"},{"key":"7163_CR36","doi-asserted-by":"publisher","unstructured":"Vona R, Cittadini C, Ortona E, et al. Sex disparity in cancer: role of autophagy and Estrogen Receptors. Cells. 2025;14(4). https:\/\/doi.org\/10.3390\/cells14040273.","DOI":"10.3390\/cells14040273"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07163-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:03:09Z","timestamp":1761091389000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07163-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7163"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07163-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Zhongshan Hospital, Fudan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was acquired from all patients for the acquisition of clinical and pathological information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1156"}}